Список литературы

Поставить закладку

Yang H., Bocchetta M., Kroczynska B., Elmishad A.G., Chen Y., Liu Z., Bubici C., Mossman B.T., Pass H.I., Testa J.R., Franzoso G., Carbone M. TNF-alpha inhibits asbestos-induced cytotoxicity via a NF-kappaB-dependent pathway, a possible mechanism for asbestos-induced oncogenesis // Proc. Natl. Acad. Sci. USA. 2006. Vol. 103. No 27. P. 10397–10402.
Carbone M., Kratzke R.A., Testa J.R. Pathogenesis of mesothelioma // Semin. Oncol. 2002. Vol. 29. No 1. P. 2–17.
Ismail-Khan R., Robinson L.A., Williams Jr C.C., Garrett C.R., Be- pler G., Simon G.R. Malignant pleural mesothelioma: a comprehensive review // Cancer Control. 2006. Vol. 13No 4. P. 255–263.
Testa J.R., Carbone M. Mesothelioma // Cancer research: an encyclopedic reference / Ed. by M. Schwab. Heidelberg: Springer-Verlay, 2002. P. 861–865.
Battifora H., McCaughey W.T.E. Tumor of serosal membranes // Atlas of tumor pathology / Ed. by J. Rosai, L.H. Sobin. Washington, 1995.
Boutin C., Schlesser M., Frenay C. et al. Malignant pleural mesothelioma // Europ. Respir. J. – 1998. – Vol. 12. – P. 972- 981
Travis WD, Colby TV, Corrin B, Shimosato Y, Brambilla E. (WHO). Histological typing of lung and pleural tumour // Berlin, Springer – 1999 – ISBN -13: 978-3-540-65219-9 8. Hierholzer J. et al. MRI and CT in the Differential Diagnosis of Pleural Disease // Chest. – 2000. – Vol. 118. – P. 604- 609.
Schouwink J.H., Kool L.S., Rutgers E.J. et al. The value of chest computer tomography and cervical mediastinoscopy in the preoperative assessment of patients with malignant pleural mesothelioma // Ann. Thorac. Surg. – 2003. – Vol. 75. – P. 1715-1719.
Heelan R.T. et al. Staging of malignant pleural mesothelioma: comparison of CT and MR imaging // AJR. Amer. J. Roent- genol. – 1999. – Vol. 172. – P.1039-1047.
Hierholzer J. et al. MRI and CT in the Differential Diagnosis of Pleural Disease // Chest. – 2000. – Vol. 118. – P. 604- 609.
Maziak D.E., Gagliardi A., Haynes A.E. et al. Surgical management of malignant pleural mesothelioma: a systematic review and evidence summary // Lung. Cancer. – 2005. – Vol. 48 (2). – P. 157- 169.
ORourke N, Garcia JC, Paul J et al. A randomized controlled trial of intervention site radiotherapy in malignant pleural mesothelioma. Radiother Oncol 2007; 84: 18–22.
Castagneto B, Bota M, Aitini E et al. Phase II study of pemetrexed in combination with carboplatin in patients with malignant pleural mesothelioma. Ann Oncol 2008; 19: 370– 373.
Vogelzang NJ, Rusthoven JJ, Symanowski J et al. Phase III study of pemetrexed in combination with cisplatin versus cisplatin alone in patients with malignant pleural mesothelioma. J Clin Oncol 2003; 21: 2636–2644.
Nakas A, Ucar M, Edwards JG, Waller DA. The role of video-assisted thoracoscopic pleurectomy/decortication in the therapeutic management of malignant pleural mesothelioma. Eur J Cardiothorac Surg 2008; 33: 83–88.
Vorobiof D.A., Mafafo K. Malignant pleural mesothelioma: medical treatment update // Clin. Lung Cancer. 2009. Vol. 10. No 2. P. 112–117.
Robinson B.W., Lake R.A. Advances in Malignant Mesothelioma // New. Engl. J. Med. – 2005. – Vol. 353. – P. 1591-603.
Nico van Zandwijk Guidelines for the diagnosis and treatment of malignant pleural mesothelioma / J Thorac Dis. 2013 Dec; 5(6): E254–E307. // Nico van Zandwijk, Christopher Clarke, Douglas Henderson, A. William Musk, Kwun Fong, Anna Nowak, Robert Loneragan, Brian McCaughan, Michael Boyer, Malcolm Feigen, David Currow , Penelope Schofield, Beth Ivimey Nick Pavlakis, Jocelyn McLean, Henry Marshall, Steven Leong, Victoria Keena, and Andrew Penman

Для продолжения работы требуется Регистрация

Предыдущая страница

Следующая страница